SARS‐CoV‐2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays
Vox Sanguinis · 2024
DOI: 10.1111/vox.13625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2024. Verfasst von Christian Renaud und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs and Innovation, Héma-Québec, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Viral, COVID-19 Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Héma-Québec, COVID-19 Immunity Task Force, Vitalant research institute.
Abstract (Originalsprache)
Background and Objectives Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) serosurveys are typically analysed by applying a fixed threshold for seropositivity (‘conventional approach’). However, this approach underestimates the seroprevalence of anti‐nucleocapsid (N) in vaccinated individuals—who often exhibit a difficult‐to‐detect anti‐N response. This limitation is compounded by delays between the onset of infection and sample collection. To address this issue, we compared the performance of four immunoassays using a new analytical approach (‘ratio‐based approach’), which determines seropositivity based on an increase in anti‐N levels. Materials and Methods Two groups of plasma donors and four immunoassays (Elecsys total anti‐N, VITROS total anti‐N, Architect anti‐N Immunoglobulin G (IgG) and in‐house total anti‐N) were evaluated. First‐group donors ( N = 145) had one positive SARS‐CoV‐2 polymerase chain reaction (PCR) test result and had made two plasma donations, including one before and one after the PCR test (median = 27 days post‐PCR). Second‐group donors ( N = 100) had made two plasma donations early in the Omicron wave.
Results
Among first‐group donors (97.9% vaccinated), sensitivity estimates ranged from 60.0% to 89.0% with the conventional approach, compared with 94.5% to 98.6% with the ratio‐based approach. Among second‐group donors, Fleiss's κ ranged from 0.56 to 0.83 with the conventional approach, compared with 0.90 to 1.00 with the ratio‐based approach.
Conclusion
With the conventional approach, the sensitivity of four immunoassays—measured in a predominantly vaccinated population based on samples collected ~1 month after a positive test result—fell below regulatory agencies requirement of ≥95%. The ratio‐based approach significantly improved the sensitivities and qualitative agreement among immunoassays, to the point where all would meet this requirement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Affairs and Innovation, Héma-Québec, Montréal, Quebec, Canada.
- Division of Microbiology, Clinical Laboratory Medicine Department, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.
- Division of Infectious Diseases, Pediatrics Department, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.
- Canadian Blood Services, Microbiology, Edmonton, Alberta, Canada.
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
- Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
ORCID-Profile: Christian Renaud, Antoine Lewin, Yves Gregoire, Steven J Drews, Sheila F O'Brien
Förderung
- Héma-Québec
- COVID-19 Immunity Task Force
- Vitalant research institute
Zitieren
APA
Renaud, C., Lewin, A., Gregoire, Y., Simard, N., Vallières, É., Paquette, M., Drews, S. J., O'Brien, S. F., Di Germanio, C., Busch, M. P., Germain, M., & Bazin, R. (2024). SARS‐CoV‐2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays. Vox Sanguinis. https://doi.org/10.1111/vox.13625
Vancouver
Renaud C, Lewin A, Gregoire Y, Simard N, Vallières É, Paquette M, et al. SARS‐CoV‐2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays. Vox Sanguinis. 2024. doi:10.1111/vox.13625
BibTeX
@article{Renaud2024,
author = {Renaud, Christian and Lewin, Antoine and Gregoire, Yves and Simard, Nathalie and Vallières, Émilie and Paquette, Maude and Drews, Steven J and O'Brien, Sheila F and Di Germanio, Clara and Busch, Michael P and Germain, Marc and Bazin, Renée},
title = {SARS‐CoV‐2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays},
journal = {Vox Sanguinis},
year = {2024},
doi = {10.1111/vox.13625}
}
EUVIMED